drugset / Trial / NCT00218153

Naltrexone Augmentation of Nicotine Patch Therapy - 1

NCT00218153

Phase 3 Completed 200 enrolled National Institute on Drug Abuse (NIDA)
RandomizedParallel-groupDouble-blindTreatment

Summary

Naltrexone Augmentation of Nicotine Patch Therapy

Timeline

Start
2000-11
Primary completion
Completion
2004-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Naltrexone Small molecule 25 mg Oral
Subject Naltrexone Small molecule 50 mg Oral
Subject Naltrexone Small molecule 100 mg Oral

Indications